|
Characteristics
|
Copy number <4.02
| |
Copy number >5.42
| |
|---|
|
OR* (95% CI)
|
P
|
OR* (95% CI)
|
P
|
|---|
|
Male vs. Female
|
2.73 (0.37-20.28)
|
0.33
|
1.89 (0.30-11.86)
|
0.50
|
|
Age
|
1.00 (0.96-1.05)
|
0.92
|
1.01 (0.97-1.05)
|
0.78
|
|
Differentiation1
|
1.02 (0.25-4.10)
|
0.98
|
0.64 (0.17-3.01)
|
0.64
|
|
Tumor invasion2
|
1.43 (0.92-2.25)
|
0.11
|
0.94 (0.60-1.46)
|
0.77
|
|
TNM stage3
|
1.53 (1.04-2.25)
|
0.03
|
1.04 (0.71-1.51)
|
0.84
|
|
LNM4
|
2.31 (0.90-5.95)
|
0.08
|
1.50 (0.58-3.89)
|
0.41
|
|
Smoking history5
|
0.46 (0.16-1.34)
|
0.16
|
0.29 (0.10-0.84)
|
0.02
|
|
Survival status6
|
0.81 (0.36-1.84)
|
0.61
|
0.79 (0.35-1.77)
|
0.56
|
- *OR: odds ratio with 95% confidence interval; 1Differentiation (well or moderate; poor or undifferentiation); 2Tumor invasion (T1; T2; T3; T4); 3TNM stage (I; II; III; IV); 4LNM (lymph node metastasis); 5Smoking history (at least 10 pack-years); 6Survival status (Alive vs. Dead); The cases with 4.02-5.42 mtDNA copies were used as reference.
